Expanding market share in healthcare is one of the fastest ways to increase enterprise value. It’s also one of the hardest.
Scale confidently. Grow enterprise value.
Mid-market healthtech and pharmacy leaders face:
Long, multi-stakeholder sales cycles that slow momentum
Fragmented decision networks across providers, systems, and partners
Uneven credibility across regions that limits pricing power
Entrenched competitors with deeper relationships and stronger brand recognition
Too many companies scale reactively, relying on disconnected tactics and untested assumptions. The result is wasted time, diluted budgets, and stalled valuation.
At Legacy DNA, we help growth-stage healthtech and pharmacy companies expand strategically with clarity, speed, and measurable impact on enterprise value.
We build scalable market expansion frameworks that align commercial strategy, demand generation, and valuation growth.
We help you:
Prioritize expansion moves that create enterprise value: Identify the markets, segments, and partnerships that deliver the highest return on growth investment
Strengthen market leadership: Elevate your brand narrative and credibility across key stakeholders including health systems, strategic partners, investors, and acquirers
Accelerate commercial performance: Align go-to-market, sales, and channel strategies to drive revenue growth, margin expansion, and valuation gains
Connect growth to valuation outcomes: Measure expansion success through ROI, pricing power, and enterprise value impact
When BioPlus Specialty Pharmacy partnered with Legacy DNA, they were respected but nearly invisible in a crowded specialty pharmacy market. Competitors were consolidating, PBM giants were tightening control, and buyers overlooked their value.
We clarified the story and built a repeatable growth engine that changed their trajectory:
Created the iconic Power of 2™ story: 2 Hour Patient Acceptance Guarantee™, 2 Day Ready to Ship™, 2 Click Refills™, a straightforward narrative customers remembered and buyers could not ignore
Enabled 13 consecutive quarters of growth by embedding as Fractional CMO and building a disciplined commercialization engine
Drove measurable outcomes:
Revenue grew $750M → $2B
Gross profit up 202% in three years
Dispenses scaled 78K → 325K in seven years (22.5% CAGR)
Positioned BioPlus for two premium exits, first to Nautic Partners/CarepathRx, then to Elevance Health
“We had something good. Legacy DNA made it better. And then some.” — Dr. Stephen Vogt, Founder and CEO, BioPlus Specialty Pharmacy
The market expansion & valuation acceleration blueprint
In as little as 90 days, we clarify where to play, how to win, and how to prove value to investors and buyers. Then we stay engaged to ensure the plan turns into momentum, not just a deck. Work often begins in our Exit Readiness Sprint™.
Market intelligence that drives smart decisions
We combine qualitative and quantitative insight to create clarity and competitive advantage.
Competitive landscape and white space opportunity mapping: See how key players position and price, and identify where you can lead instead of just competing
Market sizing and segmentation: Quantify market potential, define high-value buyer segments, and prioritize regions for scalable growth
Revenue and valuation levers: Analyze external forces, growth drivers, and market signals that influence pricing power and exit outcomes
Customer insights that reduce risk
Avoid costly missteps by understanding who truly drives adoption.
Buyer personas and adoption triggers: Identify who drives decisions and what moves them to action
Barriers-to-adoption analysis: Anticipate objections and design evidence-based strategies to overcome them
Commercial scale & valuation framework
Market positioning strategy: Strengthen credibility and leadership across provider, partner, and investor audiences
Unified messaging framework: Align your story across commercial, clinical, and capital markets to increase visibility and trust
Commercial performance plan: Optimize go-to-market execution, channel strategy, and sales enablement to expand market share and drive valuation growth
Proof that accelerates traction and valuation
Evidence packaging begins in our Premium Acquisition Sprint™ and expands through our Healthcare Growth Engine Partnership™.
Data and evidence packaging: Build investor-grade proof that validates commercial expansion and strengthens valuation
Early customer wins: Document initial success stories to establish credibility and market momentum
Growth dashboards: Track KPIs that keep leadership, boards, and investors confident
Your growth partner for scale and enterprise value
Deep healthcare focus: Exclusively focused on healthtech and pharmacy for over two decades, delivering proven growth and enterprise value. Proven, repeatable systems: Frameworks from market intelligence to valuation dashboards built on real expansion and acquisition success
Exit-driven growth: Every move planned with buyers and investors in mind to reduce risk and increase enterprise value
Hands-on partnership: We work alongside your team to turn strategy into market momentum
Leadership buyers trust: Founded by Dr. Roxie Mooney, a healthcare commercialization expert, and powered by a seasoned growth team with multiple premium exits
If you’re preparing for a future exit, your brand clarity, market position, and growth story can make or break your valuation. The Exit Readiness Scorecard™ reveals where you’re strong, where you're vulnerable, and what to fix before you enter the deal room.
Takes 5-7 minutes
10 questions across 5 valuation domains
Instant score with visual breakdown
Benchmarked against real exits and acquisition standards
